Skip Ribbon Commands
Skip to main content

​​​​​​​​​​​​

Primary Diagnosis

Atrial Fibrillation (AFib)

Study Purpose

Use of the WATCHMAN™ device without anticoagulant therapy

Principal Investigator: Steven Kindsvater, MD

Participating Physicians: Srini Potluri, MD / Pedro Nosnick, MD / Deepika Gopal, MD

Trial Details

Locations: The Heart Hospital Baylor Plano, The Heart Group, Arrhythmia Management, Legacy Heart Center, Pedro Nosnick-Neurology

Sponsor: Boston Scientific

IRB Number: 017-137

Trial Status: Enrolling

Exclusions: Adults only

Change in Care: Participating may change your care

Contact Information:

Destiny Barnett
469.814.4878
Destiny.Barnett@BSWHealth.org

Penni Dolton
469.814.4735
Penni.Dolton@BSWHealth.org​

Full Protocol Title

Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO)

Get Detailed Inf​ormation On Clinicaltrials.gov »​​​​​​​​​​​​​​

​​

​​​​​​​​​​BAYLOR SCOTT & WHITE RESEARCH ​INSTITUTE​​